AQR Capital Management - SYNTA PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2013$171,000
-59.8%
27,081
-68.2%
0.00%
-50.0%
Q2 2013$425,000
+67.3%
85,181
+202.3%
0.00%
+100.0%
Q4 2012$254,00028,1810.00%
Other shareholders

There were no reported owners of SYNTA PHARMACEUTICALS CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of SYNTA PHARMACEUTICALS CORP shareholders